Custom Search
Showing posts with label IHRD. Show all posts
Showing posts with label IHRD. Show all posts

Mar 12, 2008

Report back from Daniel Wolfe of OSI on the 51st session of the CND in Vienna, March 2008,


Report back from Daniel Wolfe of OSI:

Commission on Narcotic Drugs (CND) Opens:

Start of Year of Reflection on Progress in Drug Control since 1998



--UNODC head Costa says more attention and funding needed for harm reduction, health, and human rights; stops short of condemning death penalty


-- Thai representatives say drug war will not mean violation of international human rights standards, and pledge increased harm reduction


--Bolivia rejects INCB condemnation, says it will request rescheduling of coca leaf


--US calls for "SBIRT" to address drug use; is joined by Japan in opposing harm reduction



The 51st session of the CND, which opened in Vienna on March 10, marks the start of a year of reflection since the 1998 General Assembly session convened under the motto "A Drug Free World-We can Do it!"


The session was attended by the greatest number of health and human rights NGOs in recent years, including representatives from Alternative Georgia, the Asian Harm Reduction Network, the Beckley Foundation, Break the Chains, the Canadian HIV/AIDS Legal Network, the Eurasian Harm Reduction Network, Human Rights Watch, Intercambios, the International Drug Policy Consortium, the International Harm Reduction Association, the Open Society Institute, the Transnational Institute, Virtus (Ukraine), and others. The five-day session will include multiple NGO side events and satellites, including a briefing on human rights and drug control, another on the effects of drug law enforcement on women, and a daylong NGO forum with representatives of regional focal points from Africa, Southeast Asia, Eastern Europe and Central Asia, and Latin America reporting on consultations held since 2007. All of these, as well as a large NGO meeting to be held at UNODC headquarters in July, will feed into the 2009 high level meeting where countries will assess a decade of progress and likely issue a new declaration to direct drug control efforts.



UNODC Director Calls for more attention and funding for harm reduction, health, and human rights; stops short of condemning death penalty


Antonio Costa, executive director of the UN Office on Drugs and Crime, opened the session by stressing issues including the need for greater attention to grass roots mobilization, alternative development, health, and harm reduction. On harm reduction, he urged that countries not get caught up in sensitivities about words, and referred attendees to the UNODC discussion paper ("Reducing the adverse health and social consequences of drug abuse," available at www.unodc.org) supporting pragmatic and comprehensive approaches such as those in Australia, Canada or parts of Asia. Mr. Costa also noted that health was a basic human right and a foundation of international drug control, that too many were in prison and that too few were in treatment for illicit drugs, and that the "health principle" was a cornerstone of drug control and required greater money and commitment. Mr. Costa, however, saluted drug control in Southeast Asia without noting Thailand's recent declaration of a return to the war on drugs, said that everything UNODC did was harm reduction, and described safer injection sites as problematic while ignoring evidence showing their positive effect. While urging consideration of executions in the name of drug control-"Although drugs kill," he said, "I don't believe we need to kill because of drugs"-Mr. Costa fell well short of previous findings by UN human rights experts that drug crimes were clearly not serious enough offenses to justify death. Instead, Costa urged member states to "give serious consideration to whether capital punishment for drug-related crimes is a best practice." Some member states, including Italy, Switzerland, Netherlands and Norway, called upon UNODC and the INCB to leave no doubt about the importance of opposition to the death penalty for drug offenses.



-- Thai representatives say drug war will not mean violation of international human rights standards, and pledge increased harm reduction


More than fifty country and NGO representatives attended a side event titled "Recalibrating the Regime: Drug Control, Health, and Human Rights." Responding to comments by representatives of the International Harm Reduction Association, the Canadian HIV/AIDS Legal Network, and
Human Rights Watch, Thai representatives defended the government's return to 2003 drug war strategies, saying that the government was committed to following principles of international human rights standards; that the Prime Minister had made it clear that it was never the intention of the government to use killing as a means of suppression; that Thailand had not declared war on particular segment of the population; and that Thailand would likely adopt harm reduction measures such as methadone and "even needle exchange" in the near future, perhaps this fiscal year, in light of the increasing share of HIV cases among IDUs. At the same time, one representative said that "we cannot sit back and let things slide without taking particular measures," and observed-not happily-that the event should have been subtitled "the case of Thailand."



--Bolivia rejects INCB condemnation, says it will request rescheduling of coca leaf


Noting that the coca leaf had been a sacred and integral part of Andean culture for centuries, Bolivia delivered a strongly worded rebuke to the International Narcotics Control Board, whose 2007 report condemned coca leaf chewing as a violation of international law. Bolivia pledged to submit a request to the Secretary General to reschedule the coca leaf, based on the plants medicinal and traditional uses.



--US calls for "SBIRT" to address drug use; is joined by Japan in opposing harm reduction


The United States, noting that it supported treatment and rehabilitation and opposed harm reduction, urged all member states to endorse its resolution for "SBIRT"--screening, brief intervention and referral to treatment for drug abuse. While many member states asked privately what exactly the U.S. meant, or why such a particular intervention was being proposed as a global standard-the U.S. delegation had apparently not provided much explanation-countries from Argentina to the Netherlands expressed support for a comprehensive integrated approach, including harm reduction. Japan strongly opposed promotion of needle exchange by UNODC, noting that drug abuse itself was the fundamental problem, and Sweden noted that harm reduction would always be secondary to prevention and treatment measures.



Daniel Wolfe

Director

International Harm Reduction Development Program

Open Society Institute



WWW.HaRdCOREhARMREdUCER.BE
DrugWarLog
ArtCoreFromTheHardCore





Jan 12, 2008

In Russian: INPUD Action Alert


Уважаемые коллеги!


Вторая Конференция по вопросам СПИДа в Восточной Европе и Центральной Азии (EECAAC) будет проводиться в Москве, 3-5 мая 2008 года. EECAAC - самое значительное научное и политическое событие по вопросам ВИЧ/СПИДа в регионе, кардинально важное место встречи для обсуждения новых идей и подходов. Однако выбор Москвы местом проведения конференции может привести к тому, что голоса многих людей, непосредственно затронутых эпидемией ВИЧ, не будут услышаны вследствие запрета России на использование метадона и бупренорфина для лечения наркотической зависимости. В настоящее время эти медицинские препараты получают тысячи людей, живущих в Восточной Европе и Средней Азии, и многие из них стали лидерами в противостоянии эпидемии.

Приложенное для сбора подписей письмо содержит просьбу к организаторам Второй Конференции по вопросам СПИДа в Восточной Европе и Центральной Азии (EECAAC) обеспечить соответствующие условия для людей, получающих поддерживающую лекарственную терапию, – чтобы они могли приехать в Россию со своими лекарствами или получить лечение в помещении конференции или неподалеку, участвуя в этом форуме на законном основании, в спокойных и безопасных условиях и ощущая к себе уважительное отношение. Нам представляется критически важным, чтобы люди, наиболее пострадавшие от распространения ВИЧ в Восточной Европе и Центральной Азии, а это именно те, кто употребляет инъекционные наркотики, могли иметь возможность выступить на конференции. Только в этом случае данная конференция будет соответствовать принципам «Расширенного участия людей, живущих с ВИЧ/СПИДом» (GIPA), которые были закреплены в принятой в 2001 году Декларации о приверженности делу борьбы с ВИЧ/СПИДом и в других документах.

Мы просим, чтобы Вы подписали петицию, по возможности - от лица Вашей организации, и присоединились к нашей настоятельной просьбе к организаторам EECAAC сделать соответствующие приготовления. Кроме того мы будем благодарны, если Вы отправите петицию всем, с кем Вы сотрудничаете и кто заинтересован в защите прав людей, получающих лечение опиоидной зависимости. Чтобы добавить Ваше имя к списку подписавшихся, пожалуйста, напишите по адресу eecaac2008@gmail.com не позже 31 января 2008 г.


С искренней благодарностью,

Дэниэл Вульф, Институт «Открытое обшество»


Андрей Кастелич, Сеть лечения зависимостей Юго-Восточной Европы-Адриатики и Европейская ассоциация лечения опиоидной зависимости


Сергей Ботвин, Всеукраинская ассоциация снижения вреда


Мария Овчинникова, ФронтЭЙДС

Раминта Штуйките, Евразийская сеть снижения вреда


Наталия Леончук, Восточноевропейское и Центральноазиатское объединение ЛЖВ


Стайн Госсенс, Международная сеть людей, которые используют наркотики


Балаш Денеш, Венгерский союз гражданских свобод



31 января 2008 года


Доктору Геннадию Онищенко, Главному санитарному врачу Российской Федерации

Профессору Мишелю Казачкину, Исполнительному директору Глобального Фонда

Доктору Питеру Пиоту, Исполнительному директору ЮНЭЙДС

Крэгу МакКлюру, Исполнительному директору Международного общества по СПИДу




Уважаемые господа!


Вторая Конференция по вопросам СПИДа в Восточной Европе и Центральной Азии (EECAAC) будет проводиться в Москве, России, в мае 2008 года. Мы единодушно выражаем свою озабоченность и разочарование решением проводить конференцию в стране, где заместительное лечение опиоидной зависимости остается нелегальным. Принимая во внимание, что стадия планирования конференции в России уже завершена, мы хотели бы выразить настоятельную просьбу принять во внимание нужды людей с опиоидной зависимостью, которые получают терапию метадоном или бупренорфином, что не было сделано на Первой Конференции в 2006 году, а также при отборе следующих стран, принимающих EECAAC, включать в качестве обязательного критерия возможность предоставления заместительной терапии для участников конференции.


Конференция по вопросам СПИДа в Восточной Европе и Центральной Азии пропагандируется как форум для обсуждения и взаимодействия всех, кто занимает лидирующие позиции в усилиях по ограничению пандемии ВИЧ в регионе. Неспособность организаторов конференции обеспечить участие людей, которые получают терапию метадоном или бупренорфином, подрывают цели конференции и отвергают нужды тех, кто относится к группе высокого риска инфицирования ВИЧ или живет с ВИЧ.


Потребители инъекционных наркотиков составляют 10 процентов от общего количества ВИЧ-инфицированных в мире. В Восточной Европе и Центральной Азии, где более 1,7 миллиона человек живут с ВИЧ, инъекционное потребление наркотиков является самым существенным фактором распространения эпидемии и причиной свыше 70 процентов суммарных случаев инфицирования ВИЧ. Признавая важность применения метадона и бупренорфина в усилиях по ограничению эпидемий ВИЧ, подстегиваемых потреблением наркотиков, такие страны как Азербайджан, Беларусь, Грузия, Кыргызстан, Латвия, Литва, Молдова, Украина, Узбекистан и Эстония, среди других, начали лечебные программы с использованием данных препаратов.


Мы призываем организаторов конференции способствовать улучшению понимания преимуществ оправдавших себя медицинских препаратов, таких как метадон и бупренорфин и в настоящее время включенных в Примерный перечень жизненно важных лекарственных средств Всемирной организации здравоохранения.


Международное общество по СПИДу и его партнеры, по сути, нарушают принципы GIPA, не создав необходимых условий для участия людей, которые принимают терапию метадоном или бупренорфином. GIPA – принципы расширенного участия людей, живущих с ВИЧ и СПИДом, – были закреплены в принятой в 2001 году и подписанной Россией Декларации о приверженности делу борьбы с ВИЧ/СПИДом. Эти принципы основаны на признании важности вклада людей, живущих с ВИЧ, в эффективные ответные меры на распространение эпидемии. Исключая из диалога пациентов, получающих лечение метадоном и бупренорфином и представляющих сообщества, наиболее пострадавшие от ВИЧ/СПИДа, вы упускаете возможности для общения и обмена опытом. Пациенты поставлены в ситуацию, когда они должны будут выбрать между возможностью участия в важном региональном форуме и собственным здоровьем.


Учитывая невозможность изменения места проведения конференции, мы просим вас обеспечить выполнения следующих двух важных условий на конференции 2008 года. Во-первых, устроители конференции и правительство России должны обеспечить законный въезд в Россию и вход на конференцию по вопросам СПИДа тех участников, которые путешествуют со своими лекарственными препаратами, включая метадон и бупренорфин. Во-вторых, бупренорфин, который зарегистрирован в России для лечения болевого синдрома, должен быть доступен во время конференции для пациентов, нуждающихся в данном препарате. Мы призываем организаторов Второй Конференции по вопросам СПИДа в Восточной Европе и Центральной Азии (EECAAC) разработать вместе со Всемирной организацией здравоохранения и принять протокол лечения, который обеспечит пациентам доступ к нужным им лекарствам в месте проведения конференции или в ближайших медицинских учреждениях.


Критически важно, чтобы люди, которые пытаются снизить риск заболеваний при помощи лечения своей опиоидной зависимости, имели право принять участие в конференции. Запрещая метадон и бупренорфин, Россия отвергает один из самых эффективных методов снижения передачи ВИЧ-инфекции и улучшения приверженности лечению ВИЧ людей с опиоидной зависимостью. Конференция по вопросам СПИДа в Восточной Европе и Центральной Азии (EECAAC) и Международное общество по СПИДу должны принять незамедлительные меры к тому, чтобы изменить этот негативный сигнал на такой, который поставит интересы людей, живущих с ВИЧ, выше идеологии.



С уважением,




INPUD Action Alert: Please sign-on to and spread the EECAAC letter



You can also read this message on the INPUD website


Dear Colleagues:


The second Eastern European and Central Asian AIDS Conference (EECAAC) will be held in Moscow, Russia on 3-5 May 2008. EECAAC is the premier scientific and policy gathering on HIV/AIDS in the region, a crucially important venue for raising new ideas and approaches. Yet by choosing to hold the conference in Moscow, the voices of many people directly affected by HIV may be silenced because of Russia’s ban on methadone and buprenorphine for drug dependency treatment. Today thousands of people receive these medications in the Eastern European and Central Asian regions, and many of them have become leaders in the response to the epidemic.


The sign-on letter (below this message) requests that the EECAAC conference organizers make provisions so that individuals who receive treatment with methadone or buprenorphine may travel to Russia with their medication or access treatment at or near the conference site, in order to attend the forum in a legal, safe, comfortable and respected manner. It is crucial that people most affected by HIV in Eastern Europe and Central Asia – namely those with an experience of injection drug use – be afforded an opportunity to voice their ideas in the conference. Only in doing so would EECAAC live up to the basic principles of the Greater Involvement of People Living with HIV (GIPA) elaborated in the 2001 Declaration of Commitment on HIV/AIDS and elsewhere.


We request that you sign the letter, including if possible on behalf of your organization, and join us as we encourage the EECAAC organizers to make appropriate accommodations. In addition, we would be grateful if you forward this petition to your constituents that are interested in protecting the rights of people in treatment for opioid dependency. To add your name to the list of signatories, please write to eecaac2008@gmail.comThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it not later than 31 January 2008.


With thanks, sincerely,


Daniel Wolfe, International Harm Reduction Development, Open Society Institute


Stijn Goossens, International Network of People Who Use Drugs


Sergey Botvin, All-Ukrainian Harm Reduction Association


Maria Ovchinnikova, FrontAIDS


Raminta Stuikyte, Eurasian Harm Reduction Network


Natalya Leonchuk, Eastern European and Central Asian Union of People Living with HIV


Balazs Denesz, Hungarian Civil Liberties Union


Andrej Kastelic, South Eastern European-Adriatic Addiction Treatment Network, and European Opiate Addiction Treatment Association



To add your name to the list of signatories, please write to eecaac2008@gmail.comThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it not later than 31 January 2008.


EECAAC sign-on letter


31 January 2008


Dr. Gennady Onishchenko Chief Sanitary Physician of the Russian Federation

Professor Michel Kazatchkine Executive Director of the Global Fund

Dr. Peter Piot Executive Director of UNAIDS

Craig McClure Executive Director of the International AIDS Society



Dear Sirs:


The Eastern European and Central Asian AIDS Conference (EECAAC) will be meeting for the second time in Moscow, Russia, in May 2008. We collectively express our concern and disappointment about the decision to hold the conference in a country where opioid substitution therapy remains illegal. Because the venue for the conference has been finalized, we write to urge that the needs of opiate dependent people who receive treatment with methadone or buprenorphine are not ignored as they were during the first EECAAC in 2006, and that in determining the location of future EECAAC events, the availability of substitution therapy is considered a necessary criterion.


EECAAC is promoted as a forum for discussion and interaction among those leading the effort to contain the HIV pandemic in the region. The Russian ban on methadone and buprenorphine, and the failure of conference organizers to address this issue directly, undermines the goals of the conference and the needs of people at risk for or living with HIV.


Injection drug users comprise 10 percent of all global cases of HIV. As many as 1.7 million people are living with HIV in Eastern Europe and Central Asia, where injection drug use is the single most significant driving force behind the epidemic in the region and accounts for more than 70 percent of cumulative HIV cases. Recognizing that methadone and buprenorphine are essential tools in the effort to stop injection driven HIV epidemics, Azerbaijan, Belarus, Estonia, Georgia, Kyrgyzstan, Latvia, Lithuania, Ukraine, and Uzbekistan, among others, have initiated treatment with these medications. Some 800,000 patients, including many with important perspectives to share, are receiving treatment in Europe, the United States, Iran, China, and elsewhere. Conference organizers should be supporting scale up and greater awareness of patient benefits of these proven treatments, which are on WHO’s Model List of Essential Medicines.


The International AIDS Society and its partners are also violating GIPA principles by holding the conference in Russia. GIPA, which stands for the greater involvement of people living with HIV and AIDS, is a principle enshrined in the 2001 Declaration of Commitment on HIV/AIDS, to which Russia is a signatory, and is based on the idea that the input of people with HIV is essential to an effective response to the epidemic. By excluding methadone and buprenorphine patients who represent communities most affected by HIV/AIDS from the dialogue, you forfeit a chance for experience sharing. Patients are put in the position of having to choose between participation in an important regional forum and their personal health.


Since it is not possible to move the conference, we ask that two conditions are met in 2008. First, conference organizers and the Russian government must work to ensure that conference participants able to travel with their medication will be legally permitted to enter Russia and the AIDS conference with methadone and buprenorphine. Second, buprenorphine, a drug registered for pain management in Russia, should be made available during the conference to patients who need it. We call on the EECAAC organizers to work as necessary with the World Health Organization to adopt a treatment protocol which will allow for patients to access medications on-site or at a clinic located near the conference.


It is crucial that individuals trying to decrease their risk of illness by treating their opiate addiction have the right to attend the conference. By banning methadone and buprenorphine, Russia is denying one of the most effective tools to decrease HIV transmission and improve adherence to HIV treatment for opiate dependent people. EECAAC and the IAS must take immediate action to replace this negative message with one that emphasizes the needs of people with HIV ahead of ideology.



Sincerely,




To add your name to the list of signatories, please write to eecaac2008@gmail.comThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it not later than 31 January 2008.


Oct 29, 2007

Seeking Comments on "Greater Involvement" Manifest

Stijn (Belgium), Matt (USA) and Alexander (Russia)

Dear friends and colleagues,

As you may know, the Canadian HIV/AIDS Legal Network, with support from OSI’s International Harm Reduction Development Program and the International HIV/AIDS Alliance, is preparing two new editions of their report Nothing About Us Without Us: Greater, Meaningful Involvement of People Who Use Illegal Drugs. One new edition is specifically for the former Soviet Union, and one is more broadly international (the original report was primarily focused on Canada). Along with the report itself, it includes a Manifesto, the original version of which was written by people who use drugs from Canadian organizations.

A number of you participated in previous discussions for the international edition, for example at the consultation we organized in Warsaw during this year’s harm reduction conference, or in the discussion of part of the project that Ann Livingston and I moderated during the 2nd Users Congress. The international edition is now nearing completion, and we are especially interested in getting additional comments about the Manifesto. The latest copy is attached to this message.

We welcome any and all comments, suggestions or questions, and ask only that you respond to this address: idu-udi-int@aidslaw.caThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it not later than November 20, 2007.


Thanks!
Matt Curtis (IHRD) and Ralf Jürgens (Canadian HIV/AIDS Legal Network)

Read the document here:

Greaterinvolvementmanifesto.doc

Reply to this message on the INPUD forum



WWW.HaRdCOREhARMREdUCER.BE
DrugWarLog
ArtCoreFromTheHardCore




Sep 4, 2007

IHRD/OSI calls for letters of intent


Call for Letters of Intent

I. Introduction


The International Harm Reduction Development Program (IHRD) of the Open Society Institute (OSI) is offering small grants to support the collection and presentation of information that evaluate the health and human rights consequences, with regard to injection drug use-driven and HIV infections, of the resolutions taken at the 1998 UN General Assembly Special Session on Drugs.


This project will provide grants of up to $12,000 USD for organizations or networks able to produce a report in English on how law enforcement and drug control have impacted HIV prevention and treatment efforts for drug users in their country or region. The reports, to be gathered from developing/transitional countries with injection-driven HIV epidemics (either majority of cases of HIV due to injection, or significant, concentrated IDU epidemic), will be edited and compiled in a booklet to be published by IHRD during activities leading up to the high-level ministerial meeting in Vienna in 2009 at which countries will reflect on progress since the 1998 UNGASS. Preference will be given to proposals that have a regional, rather than country specific, focus.


This document serves as a formal invitation to submit a letter of intent (LoI). This brief concept paper allows you the opportunity to both demonstrate your understanding of the aim of this project and your perspective of how it can be realized in your region. While there are many aspects to health, policing, and drug control, applicants must demonstrate a particular connection to policies and practices tied to HIV and drug use, particularly injecting drug use.


The LoI must:


  1. be received by Wednesday, September 15, 2007 (NY time), electronically as an attachment.

  2. be addressed to IHRD@sorosny.orgThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it , with a subject line of UNGASS+10 LoI with a copy to famesq@terra.com.brThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it

  3. be submitted in English, not to exceed three pages, double-spaced, that outlines key issues, existing evidence, and potential sources for more detailed information

  4. contain a two-sentence introduction and contact information on each of the individuals submitting the grant.


IHRD will review your LoIs and notify you by the end of September. If accepted, you will be invited to submit a slightly expanded proposal and budget. We hope to have final proposals by mid-October, and decisions by November. Any questions about the application process of applying should be addressed to Fabio Mesquita ( famesq@terra.com.brThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it ).




II. Structure and Content of the LoI


Your Letter of Intent should address the following questions:

  1. Concept of the Report

How can your organization or network contribute to evaluate and describe the health consequences (particularly HIV/AIDS epidemic related to the use of injectable drugs) as a consequence of the decisions made at UNGASS (United Nations General Assembly Special Session on Drugs) in 1998? Start describing the problem in your region, then the conditions which make this an issue of national or international relevance. international issue in the developing world.

  1. Report Goals and Objectives

Please describe your proposed activity, including timeline, capacity and potential partners or sources of information to document:


  1. the number of estimated people who inject drugs in 1998 and in 2008;

  2. the number of HIV cases related to people who inject drugs in 1998 and in 2008;

  3. numbers of people imprisoned on drug charges, as absolute numbers and share of total, in 1998 and in 2008

  4. reports on injection inside of the prison system, HIV or HCV epidemic in prisons in 2008;

  5. substitution therapy and sterile syringe programs in prison, and where relevant, possible waiting lists status;

  6. Drug treatment in “closed settings” in your country/region, numbers in such treatment facilities, and means for introduction and release of drug users into these institutions

  7. Barriers to access treatment (particularly substitution treatment);

  8. Availability of HIV prevention for IDUs -(such as needle exchange, outreach work and condom distribution among others) with estimated coverage and some detail about what is meant by coverage;

  9. Barriers to access prevention or drug treatment;

  10. ARV treatment given to those with a history of drug use, and to active users, or regulations regarding such treatment, and informal practices that might impact its provision

  11. Violations of human rights of drug users by police and health care providers

  12. Other relevant information.

  1. Implementation

How long would you take to get this information and write your report? What is the scope (regionally speaking) of your possible report (one country, one entirely region, one piece of the region)? How does your country or region match the profile of one where IDU-driven HIV is a significant issue?

  1. Capacity and Resources

Describe how the organization applying for this grant is in a position to undertake this project. Who would the organization designate to take care of this report? What existing sources of information might you draw on? What partners might assist in provision of information?


WWW.HaRdCOREhARMREdUCER.BE
DrugWarLog
ArtCoreFromTheHardCore


 
Blog Directory - Blogged